Fortress Biotech, Inc.FBIOPEarnings & Financial Report
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.
FBIOP Q3 2025 Key Financial Metrics
Revenue
$17.6M
Gross Profit
$11.9M
Operating Profit
$-6.8M
Net Profit
$5.8M
Gross Margin
67.4%
Operating Margin
-38.6%
Net Margin
33.2%
YoY Growth
20.5%
EPS
$0.11
Financial Flow
Fortress Biotech, Inc. Q3 2025 Financial Summary
Fortress Biotech, Inc. reported revenue of $17.6M for Q3 2025, with a net profit of $5.8M (33.2% margin). Cost of goods sold was $5.8M, operating expenses totaled $18.7M.
Key Financial Metrics
| Total Revenue | $17.6M |
|---|---|
| Net Profit | $5.8M |
| Gross Margin | 67.4% |
| Operating Margin | -38.6% |
| Report Period | Q3 2025 |
Fortress Biotech, Inc. Annual Revenue by Year
Fortress Biotech, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $57.7M).
| Year | Annual Revenue |
|---|---|
| 2024 | $57.7M |
| 2023 | $84.5M |
| 2022 | $75.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.9M | $13.0M | $14.9M | $14.6M | $15.1M | $13.1M | $16.4M | $17.6M |
| YoY Growth | 21.6% | 4.8% | -14.3% | -57.9% | -24.2% | 0.8% | 10.2% | 20.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $167.5M | $164.6M | $145.7M | $127.1M | $144.2M | $178.1M | $159.9M | $181.4M |
| Liabilities | $165.9M | $168.6M | $160.3M | $139.8M | $145.9M | $145.6M | $122.5M | $116.2M |
| Equity | $22.5M | $23.0M | $17.9M | $21.2M | $22.7M | $22.3M | $43.9M | $55.9M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-34.9M | $-25.4M | $-21.8M | $-20.1M | $-12.9M | $-19.6M | $-27.6M | $-6.1M |
More Companies
THC
TENET HEALTHCARE CORP
Revenue
$5.3B
Net Profit
$579.0M
FMS
Fresenius Medical Care AG
EHC
Encompass Health Corp
Revenue
$1.5B
Net Profit
$126.5M
BTSG
BrightSpring Health Services, Inc.
Revenue
$3.3B
Net Profit
$55.8M
OPCH
Option Care Health, Inc.
Revenue
$1.4B
Net Profit
$51.8M
CON
Concentra Group Holdings Parent, Inc.
Revenue
$572.8M
Net Profit
$48.3M
NHC
NATIONAL HEALTHCARE CORP
Revenue
$382.7M
Net Profit
$39.2M
SGRY
Surgery Partners, Inc.
Revenue
$821.5M
Net Profit
$-22.7M
SEM
SELECT MEDICAL HOLDINGS CORP
Revenue
$1.4B
Net Profit
$28.8M
DHC
DIVERSIFIED HEALTHCARE TRUST
Revenue
$388.7M
Net Profit
$-164.0M